Post-Operative Thoracolumosacral Orthosis for PJK
The Use of a Novel Post-Operative Thoracolumosacral Orthosis for Prevention of Proximal Junctional Kyphosis After Adult Spinal Deformity Surgery
1 other identifier
interventional
84
1 country
6
Brief Summary
Proximal junctional kyphosis (PJK) is a common post-operative radiographic finding after surgery for adult spinal deformity (ASD) patients. Although the clinical relevance of isolated PJK is unclear, PJK can progress to symptomatic proximal junctional failures which requires a large revision surgery. Currently, post-operative bracing with a thoracolumbosacral orthosis (TLSO) is common practice after spinal deformity surgery, however the efficacy of this in preventing PJK is unknown. This multi-center randomized control trial identified 84 patients undergoing thoracolumbosacral fusion for ASD and plans to study the efficacy of a novel post-operative TLSO in preventing the development of PJK as defined by the proximal junctional angle on 6-month post-operative X-rays.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Dec 2024
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2024
CompletedFirst Posted
Study publicly available on registry
July 8, 2024
CompletedStudy Start
First participant enrolled
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 13, 2026
January 1, 2026
2 years
June 20, 2024
February 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of proximal junctional kyphosis development
As defined by a proximal junctional angle both ≥10° and 10°greater than pre-operative values.
This will be measured via scoliosis radiographs at the pre discharge, 6-week, and 6-month time points.
Secondary Outcomes (2)
Change in patient reported outcome measures
6 week and 6-month time points
Change in patient reported outcome measures
6 week and 6-month time points
Study Arms (2)
Thoracolumosacral Orthosis
EXPERIMENTALPatients randomized to this arm will be fitted with an Aspen Medical Products "Align PJK™" TLSO brace. This is a 3-point, rigid hyperextension TLSO brace which is currently FDA approved under a 510k exemption but not commercially available. With this brace, the sternal pad height/width and belt component will be adjusted to optimize patient position and comfort. The brace will also be fitted with an external temperature sensing probe. Patients will be instructed to wear the brace at all times, including when in bed for 6-weeks post-operatively. At the 6-week visit patients will be asked to self-report compliance with the brace
No brace
PLACEBO COMPARATORPatients in the control arm will be treated without a brace but will have no other differences in their post-operative treatment protocol. This will be considered "usual care" for the purposes of this study.
Interventions
Patients will get randomized to receiving and wearing a back brace for 6 weeks postoperatively.
Patients will receive the standard of care postoperative instructions without a brace
Eligibility Criteria
You may qualify if:
- years-old
- Undergoing primary thoracolumbosacral fusion for ASD with an upper instrumented vertebrae (UIV) between T8-L2 and lower instrumented vertebrae (LIV) of S1 or the ilium.
You may not qualify if:
- Osteoporosis (defined as a T-score \<-2.5 at the time of surgery)
- Body mass index (BMI) \>35 kg/m2
- Revision fusions
- Fusions for trauma
- Those with a neuromuscular etiology for their deformity (i.e. Parkinson's disease, cerebral palsy, post-stroke, etc.)
- An underlying inflammatory arthropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital for Special Surgery, New Yorklead
- Aspen Medical Productscollaborator
Study Sites (6)
Indiana Spine Group
Carmel, Indiana, 46032, United States
University of Kansas
Overland Park, Kansas, 66211, United States
Hospital for Special Surgery
New York, New York, 10021, United States
University of Texas Health, Houston
Bellaire, Texas, 77401, United States
Texas Back Institute
Dallas, Texas, 75243, United States
Virgina Mason Franciscan Health
Seattle, Washington, 98101, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2024
First Posted
July 8, 2024
Study Start
December 2, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 13, 2026
Record last verified: 2026-01